Latest Articles

Publication Date
Mali Barbi: ASCO 2026 Endometrial Cancer Recap Highlights Potential Curative Signal in dMMR Subtype - Oncodaily

Mali Barbi: ASCO 2026 Endometrial Cancer Recap Highlights Potential Curative Signal in dMMR Subtype Oncodaily

Published: June 7, 2026, 6:12 a.m.
Initial Results of FAPI PET/MRI to Assess the Extent of Endometriosis.

Endometriosis is a common gynecologic disorder often associated with chronic pelvic pain, infertility, and reduced quality of life. Conventional imaging modalities, such as transvaginal ultrasound and MRI, may underestimate the …

Published: June 4, 2026, midnight
UCA1 facilitates endometriosis progression through EIF4A3-mediated stabilization of E2F1 mRNA and enhanced glycolysis.

Long non-coding RNA Urothelial carcinoma-associated 1 (UCA1) is a pivotal regulator in the progression of endometriosis (EMs), yet its mechanistic role remains elusive. This study identified UCA1 as a factor …

Published: June 2, 2026, midnight
Puxitatug Samrotecan Elicits High Response Rate in Select Endometrial Cancers - OncLive

Puxitatug Samrotecan Elicits High Response Rate in Select Endometrial Cancers OncLive

Published: May 30, 2026, 9:59 p.m.
Long-Term RUBY Data Show Potential for Curative Intent With Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer - OncLive

Long-Term RUBY Data Show Potential for Curative Intent With Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer OncLive

Published: May 30, 2026, 12:24 a.m.
Dostarlimab Plus Chemotherapy Yields Curative Potential in dMMR/MSI-H Endometrial Cancer - CancerNetwork

Dostarlimab Plus Chemotherapy Yields Curative Potential in dMMR/MSI-H Endometrial Cancer CancerNetwork

Published: May 29, 2026, 10:40 p.m.
Dostarlimab/Chemo Shows Curative Potential in dMMR/MSI-H Advanced Endometrial Cancer - Targeted Oncology

Dostarlimab/Chemo Shows Curative Potential in dMMR/MSI-H Advanced Endometrial Cancer Targeted Oncology

Published: May 29, 2026, 10:11 p.m.
Aberrant mRNA Splicing Fuels Endometriotic Cell Growth - Bioengineer.org

Aberrant mRNA Splicing Fuels Endometriotic Cell Growth Bioengineer.org

Published: May 29, 2026, 7:56 p.m.
Correction: Misregulated alternative splicing in endometriosis: a role for aberrant mRNA variants in endometriotic cell growth.

Published: May 29, 2026, midnight
An ensemble machine learning model based on magnetic resonance imaging features for diagnosing deep infiltrating endometriosis.

To address the need for more objective and reproducible preoperative diagnosis of deep infiltrating endometriosis (DIE), this study aimed to develop and validate a weighted ensemble machine learning (ML) model …

Published: May 29, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!